Pramodini Medicare Ltd
We are a diagnostic service provider in India. We provide a range of technology-enabled diagnostic services such as radiology, clinical laboratory and nuclear medicine service to public hospitals, private hospitals, certain PSU (Public Sector Undertaking) of Government of India and medical colleges across tier I, tier II and tier III cities throughout India. Our diagnostic services include a comprehensive range of offerings: (i) "Radiology" which covers Magnetic Resonance Imaging (MRI), Computed Tomography (CT scan), X- ray, Ultrasound with colour doppler, Mammography, Dexa Scan and Intervention Radiology, (ii) "Clinical Laboratory" which includes Haematology, Micro-Biology, Immunology, Pathology & Bio-Chemistry and (iii) "Nuclear Medicine" which includes PET-CT (Positron Emission Tomography-Computed Tomography), SPECT (Single Photon Emission Computed Tomography) and Nuclear therapy. We also provide teleradiology services through our registered office situated at Vijayawada which functions on a 24x7 basis throughout the year. We provide healthcare services for core testing, patients diagnosis, disease prevention and monitoring of various health conditions. Our services includes both routine and specialized tests, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of diseases.
Timeline
Subscription
Reports
Offer Details
Terms
Application Sizes
Managers & Registrar
Ownership & Proceeds
Offer for Sale
Shareholding
Objects of the Issue
- Funding of capital expenditure for purchase of Medical Equipments towards Existing and Proposed Diagnostic Centres; and
- General corporate purposes and unidentified inorganic acquisition
Anchor Book
Financials
Profit & Loss
| Financial Year | FY24 | FY25 | FY26 |
|---|---|---|---|
| RevenueCr | 35 | 38 | 62 |
| Operating ProfitCr | 16 | 21 | 31 |
| OPM% | 44.1 | 54.8 | 49.6 |
| PBTCr | 10 | 16 | 23 |
| PATCr | 7 | 11 | 17 |
| EPS | 4 | 7 | 10 |
Balance Sheet
| Financial Year | FY24 | FY25 | FY26 |
|---|---|---|---|
| Equity CapitalCr | 1 | 1 | 17 |
| ReservesCr | 23 | 34 | 36 |
| BorrowingsCr | 12 | 11 | 18 |
| Total AssetsCr | 49 | 56 | 94 |
Cash Flow
| Financial Year | FY24 | FY25 | FY26 |
|---|---|---|---|
| Operating Cash FlowCr | 10 | 22 | 25 |
| Investing Cash FlowCr | -1 | -15 | -31 |
| Financing Cash FlowCr | -11 | -2 | 6 |
| Net Cash FlowCr | -2 | 5 | 1 |
Strengths & Risks
- Establishing a Strategic presence across various states of India.
- Strengthening Our Network with Diversified Models.
- Technical Capability with robust IT Infrastructure.
- Dedicated Management Team with Significant Industry Experience.
- Track record of revenue and financial performance.
- Diverse Customer cum Patient Base.
- Expanding geographic footprint across the India.
- Increase in capacities at our existing diagnostic facilities.
- Expand our business and geographical footprint through opportunistic acquisitions.
- Continue to improve profitability and efficiency.
- Enhancing our brand image.
- A significant portion of the company's revenue from operations is derived from MOUs with government authorities under Public Private Partnership (PPP) arrangements. Any non-renewal, modification, or termination of such MOUs, or delays or failures in realizing payments from government authorities, may materially and adversely affect its business, financial condition and results of operations.
- Concentrated emphasis on radiology services also exposes it to substantial risks that could adversely impact the company's operations, financial performance, and long-term growth prospects.
- The company derives substantial portion of its revenue from the state of Andhra Pradesh and any loss of business in such regions could have an adverse effect on the company's business, results of operations and financial condition.
- The company is majorly dependent on certain key customers cum patients for a substantial portion of its revenues. Loss of relationship with any of these customers cum patients may have a material adverse effect on the company's profitability and results of operations.
- The company derives a significant portion of its revenue from government authorities (B2G). Any reduction in revenue from them or delays in payments by government authorities, may adversely affect the company's business, financial condition and results of operations.
- Failures to establish and comply with appropriate quality standards when performing diagnostics services could result in litigation and liability for it and could materially and adversely affect its reputation and results of operations.